Requested article is recognized. But, there is no holdings information available for it.
A notification was automatically sent to our data department to investigate. The information below was supplied.
Please check in a few days to see if it has been corrected.
Article:MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients
Source:Yearbook of Neurology and Neurosurgery, Volume 2009, Issue null, Pages 122-123